Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DBVT vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1669.52T
5Y Perf.-59.8%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.60B
5Y Perf.-78.7%

DBVT vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DBVT logoDBVT
PRGO logoPRGO
IndustryBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$1669.52T$1.60B
Revenue (TTM)$0.00$4.25B
Net Income (TTM)$-168M$-1.43B
Gross Margin35.1%
Operating Margin-26.4%
Forward P/E5.5x
Total Debt$22M$37M
Cash & Equiv.$194M$532M

DBVT vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DBVT
PRGO
StockMay 20May 26Return
DBV Technologies S.… (DBVT)10040.2-59.8%
Perrigo Company plc (PRGO)10021.3-78.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: DBVT vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PRGO leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. DBV Technologies S.A. is the stronger pick specifically for profitability and margin quality and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
DBVT
DBV Technologies S.A.
The Quality Compounder

DBVT is the clearest fit if your priority is quality and momentum.

  • 0.3% margin vs PRGO's -33.5%
  • +110.7% vs PRGO's -49.3%
Best for: quality and momentum
PRGO
Perrigo Company plc
The Income Pick

PRGO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 10 yrs, beta 1.18, yield 9.9%
  • Rev growth -2.8%, EPS growth -7.2%, 3Y rev CAGR -1.5%
  • -78.5% 10Y total return vs DBVT's -87.1%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthPRGO logoPRGO-2.8% revenue growth vs DBVT's -100.0%
Quality / MarginsDBVT logoDBVT0.3% margin vs PRGO's -33.5%
Stability / SafetyPRGO logoPRGOBeta 1.18 vs DBVT's 1.26, lower leverage
DividendsPRGO logoPRGO9.9% yield; 10-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.7% vs PRGO's -49.3%
Efficiency (ROA)PRGO logoPRGO-16.7% ROA vs DBVT's -89.0%

DBVT vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DBVTDBV Technologies S.A.

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

DBVT vs PRGO — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

DBVT leads this category, winning 1 of 1 comparable metric.

PRGO and DBVT operate at a comparable scale, with $4.3B and $0 in trailing revenue.

MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$0$4.3B
EBITDAEarnings before interest/tax-$112M-$1.1B
Net IncomeAfter-tax profit-$168M-$1.4B
Free Cash FlowCash after capex-$151M$145M
Gross MarginGross profit ÷ Revenue+35.1%
Operating MarginEBIT ÷ Revenue-26.4%
Net MarginNet income ÷ Revenue-33.5%
FCF MarginFCF ÷ Revenue+3.4%
Rev. Growth (YoY)Latest quarter vs prior year-2.5%
EPS Growth (YoY)Latest quarter vs prior year+91.5%-31.0%
DBVT leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

PRGO leads this category, winning 2 of 2 comparable metrics.
MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
Market CapShares × price$1669.52T$1.6B
Enterprise ValueMkt cap + debt − cash$1669.52T$1.1B
Trailing P/EPrice ÷ TTM EPS-0.74x-1.13x
Forward P/EPrice ÷ next-FY EPS est.5.52x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.38x
Price / BookPrice ÷ Book value/share0.64x0.55x
Price / FCFMarket cap ÷ FCF11.04x
PRGO leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

PRGO leads this category, winning 7 of 8 comparable metrics.

PRGO delivers a -48.6% return on equity — every $100 of shareholder capital generates $-49 in annual profit, vs $-130 for DBVT. PRGO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), PRGO scores 5/9 vs DBVT's 4/9, reflecting solid financial health.

MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-130.2%-48.6%
ROA (TTM)Return on assets-89.0%-16.7%
ROICReturn on invested capital-17.1%
ROCEReturn on capital employed-145.7%-13.9%
Piotroski ScoreFundamental quality 0–945
Debt / EquityFinancial leverage0.13x0.01x
Net DebtTotal debt minus cash-$172M-$495M
Cash & Equiv.Liquid assets$194M$532M
Total DebtShort + long-term debt$22M$37M
Interest CoverageEBIT ÷ Interest expense-189.82x-6.91x
PRGO leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in PRGO five years ago would be worth $4,057 today (with dividends reinvested), compared to $3,041 for DBVT. Over the past 12 months, DBVT leads with a +110.7% total return vs PRGO's -49.3%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs PRGO's -25.1% — a key indicator of consistent wealth creation.

MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date+2.3%-14.1%
1-Year ReturnPast 12 months+110.7%-49.3%
3-Year ReturnCumulative with dividends+18.1%-58.0%
5-Year ReturnCumulative with dividends-69.6%-59.4%
10-Year ReturnCumulative with dividends-87.1%-78.5%
CAGR (3Y)Annualised 3-year return+5.7%-25.1%
DBVT leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — DBVT and PRGO each lead in 1 of 2 comparable metrics.

PRGO is the less volatile stock with a 1.18 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 74.4% from its 52-week high vs PRGO's 40.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.26x1.18x
52-Week HighHighest price in past year$26.18$28.44
52-Week LowLowest price in past year$7.53$9.23
% of 52W HighCurrent price vs 52-week peak+74.4%+40.9%
RSI (14)Momentum oscillator 0–10043.750.2
Avg Volume (50D)Average daily shares traded249K3.3M
Evenly matched — DBVT and PRGO each lead in 1 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Wall Street rates DBVT as "Buy" and PRGO as "Hold". Consensus price targets imply 137.7% upside for DBVT (target: $46) vs 71.8% for PRGO (target: $20). PRGO is the only dividend payer here at 9.88% yield — a key consideration for income-focused portfolios.

MetricDBVT logoDBVTDBV Technologies …PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$46.33$20.00
# AnalystsCovering analysts1536
Dividend YieldAnnual dividend ÷ price+9.9%
Dividend StreakConsecutive years of raises010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

PRGO leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). DBVT leads in 2 (Income & Cash Flow, Total Returns). 1 tied.

Best OverallPerrigo Company plc (PRGO)Leads 3 of 6 categories
Loading custom metrics...

DBVT vs PRGO: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is DBVT or PRGO a better buy right now?

Analysts rate DBV Technologies S.

A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — DBVT or PRGO?

Over the past 5 years, Perrigo Company plc (PRGO) delivered a total return of -59.

4%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: PRGO returned -78. 5% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — DBVT or PRGO?

By beta (market sensitivity over 5 years), Perrigo Company plc (PRGO) is the lower-risk stock at 1.

18β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 6% more volatile than PRGO relative to the S&P 500. On balance sheet safety, Perrigo Company plc (PRGO) carries a lower debt/equity ratio of 1% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.

04

Which is growing faster — DBVT or PRGO?

On earnings-per-share growth, the picture is similar: DBV Technologies S.

A. grew EPS -347. 5% year-over-year, compared to -723. 2% for Perrigo Company plc. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — DBVT or PRGO?

DBV Technologies S.

A. (DBVT) is the more profitable company, earning 0. 0% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DBVT leads at 0. 0% versus -26. 4% for PRGO. At the gross margin level — before operating expenses — PRGO leads at 35. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is DBVT or PRGO more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 137.

7% to $46. 33.

07

Which pays a better dividend — DBVT or PRGO?

In this comparison, PRGO (9.

9% yield) pays a dividend. DBVT does not pay a meaningful dividend and should not be held primarily for income.

08

Is DBVT or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

18), 9. 9% yield). Both have compounded well over 10 years (PRGO: -78. 5%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between DBVT and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DBVT is a mega-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while DBVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 21%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.